RAC1 and neoplasm: Therapeutically increasing the generation of Rac1b over that of Rac1 in the tumour tissue, e.g. by shifting the splice ratio45 could be a means to block some undesired effects of hyperactive Ras and may represent a promising strategy for alleviating the protumourigenic effects of TGF-β.